EUVIMEDEUVIMED entdecken
Open Access

Transperineal Laser Ablation of Symptomatic Benign Prostatic Hyperplasia With Median‐Lobe Enlargement: A Single‐Center Experience

Antonio Ruffo iD, Nikola Stanojevic, Felice Crocetto, Biagio Barone iD, Petr Holy, Vincenzo Maria Altieri, Lorenzo Spirito iD, Fabio Esposito

Lasers in Surgery and Medicine · 2026-09 · 58 (7) · 524-531

DOI: 10.1002/lsm.70149 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Lasers in Surgery and Medicine, online erschienen am 18.05.2026. Verfasst von Antonio Ruffo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Health Sciences ''V. Tiberio'', University of Molise, Campobasso, Italy. Hauptthemen laut MEDLINE: Prostatic Hyperplasia, Laser Therapy, Lasers, Semiconductor. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Benign prostatic hyperplasia (BPH) with median‐lobe enlargement (MLE) is a distinct and challenging clinical entity contributing to lower urinary tract symptoms (LUTS). Minimally invasive treatments, such as transperineal laser ablation (TPLA), offer potential advantages in treating this subgroup, but limited data exist regarding their outcomes. The aim of this study is to evaluate the efficacy and safety of EchoLaser TPLA of symptomatic BPH with MLE.

Methods

This study retrospectively evaluated 31 patients with symptomatic BPH and MLE who underwent EchoLaser TPLA at a private clinic. EchoLaser TPLA was performed with a proprietary 1064‐nm continuous‐wave diode laser. Baseline and 6‐month follow‐up assessments included International Prostate Symptom Score (IPSS), quality of life (QoL), prostate volume (PV), postvoid residual (PVR), peak urinary flow rate (Q max ), and International Index of Erectile Function (IIEF‐15). Safety outcomes were categorized using the Clavien–Dindo classification system.

Results

EchoLaser TPLA significantly improved IPSS (median 22 to 6.5; p < 0.001), QoL (median 5 to 1; p < 0.001), PV (median 105 mL to 43 mL; p < 0.001), PVR (median 120 mL to 23.5 mL; p < 0.001), and Q max (median 7.6 mL/s to 15.95 mL/s; p < 0.001) at 6 months. IIEF‐15 scores remained stable, indicating preservation of erectile function. No intraoperative adverse events occurred; two mild periprocedural events (urinary tract infection, hematuria) were successfully managed conservatively. Nine of 10 catheter‐dependent patients resumed normal voiding.

Conclusion

EchoLaser TPLA is an effective and safe minimally invasive treatment for BPH with MLE, offering significant symptomatic relief, functional improvement, and a favorable safety profile while preserving sexual function. These findings position EchoLaser TPLA as a promising alternative to conventional treatments for this challenging patient subgroup.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic HyperplasiaLaser TherapyLasers, SemiconductorHumansMaleRetrospective StudiesAgedTreatment OutcomeMiddle AgedQuality of LifeLower Urinary Tract SymptomsFollow-Up StudiesPerineum

Stichwörter der Autor:innen

benign prostatic hyperplasialower urinary tract symptomsmedian‐lobe enlargementminimally invasive therapytransperineal laser ablation

Autor:innen und Institutionen

  • Department of Medicine and Health Sciences ''V. Tiberio'', University of Molise, Campobasso, Italy.
  • Urogenital Center, Belgrade, Serbia.
  • Department of Neurosciences and Reproductive Sciences and Odontostomatology, University of Naples Federico II, Naples, Italy.
  • Department of Urology, Ospedale San Paolo, ASL NA1, Naples, Centro, Italy.
  • Urosante, Prague, Czech Republic.
  • Department of Woman, Child and General and Specialized Surgery, Unit of Urology, University of Campania "Luigi Vanvitelli", Napoli, Italy.

ORCID-Profile: Antonio Ruffo, Biagio Barone, Lorenzo Spirito

Zitieren

APA

Ruffo, A., Stanojevic, N., Crocetto, F., Barone, B., Holy, P., Altieri, V. M., Spirito, L., & Esposito, F. (2026). Transperineal Laser Ablation of Symptomatic Benign Prostatic Hyperplasia With Median‐Lobe Enlargement: A Single‐Center Experience. Lasers in Surgery and Medicine, 58(7), 524-531. https://doi.org/10.1002/lsm.70149

Vancouver

Ruffo A, Stanojevic N, Crocetto F, Barone B, Holy P, Altieri VM, et al. Transperineal Laser Ablation of Symptomatic Benign Prostatic Hyperplasia With Median‐Lobe Enlargement: A Single‐Center Experience. Lasers in Surgery and Medicine. 2026;58(7):524-531. doi:10.1002/lsm.70149

BibTeX
@article{Ruffo2026,
  author = {Ruffo, Antonio and Stanojevic, Nikola and Crocetto, Felice and Barone, Biagio and Holy, Petr and Altieri, Vincenzo Maria and Spirito, Lorenzo and Esposito, Fabio},
  title = {Transperineal Laser Ablation of Symptomatic Benign Prostatic Hyperplasia With Median‐Lobe Enlargement: A Single‐Center Experience},
  journal = {Lasers in Surgery and Medicine},
  year = {2026},
  volume = {58},
  number = {7},
  pages = {524--531},
  doi = {10.1002/lsm.70149}
}
Kostenlos starten →